Ronald K. Hull, MD Pain Medicine - Interventional Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Park Dr, Helena, MT 59601 Phone: 406-457-8244 Fax: 406-457-8236 |
News Archive
Even the least graceful among us has motor control the most high-tech unmanned undersea vehicle would envy, thanks to a region of the brain that allows our bodies to carry out complex maneuvers. The Office of Naval Research, which traditionally relies on the power of the human mind to achieve breakthroughs in science and technology, now also is harnessing the working principle of the brain to control the maneuvers of UUVs.
According to EU legislation, clinical trials must be prospectively registered in the European Union Clinical Trials Register and the main results must be reported there one year after completion of the trial. This information is thus publicly available.
Bristol-Myers Squibb (NYSE: BMY) and Enterome SA (Enterome), a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announced that they have entered into an Immuno-Oncology focused collaboration agreement for the discovery and development of microbiome-derived biomarkers, drug targets and bioactive molecules to be developed as potential companion diagnostics and therapeutics for cancer.
Results from a new study showed that coadministration of Zetia (ezetimibe) and fenofibrate significantly reduced LDL ("bad") cholesterol (LDL-C), non-high density lipoprotein cholesterol (non-HDL-C) and apo B1 in patients with mixed hyperlipidemia and high LDL cholesterol when compared to fenofibrate alone.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) have identified a potential drug combination to treat uveal melanoma, a type of eye cancer.
› Verified 6 days ago